Sat 26 Sep 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| VORICONAZOLE | VORIC | 200 | Powder for solution for infusion | 295 | Details |
| Capecitabine | Catabina | 500 | Film-coated tablet | 978.80 | Details |
| SODIUM CHLORIDE | 7.5% Sodium Chloride Intravenous Infusion | 7.5 | Solution for infusion | 34.50 | Details |
| OLMESARTAN MEDOXOMIL,HYDROCHLOROTHIAZIDE | Olcontro HCT | 20,12.5 | Film-coated tablet | 47.95 | Details |
| OLMESARTAN MEDOXOMIL,HYDROCHLOROTHIAZIDE | Olcontro HCT | 40,12.5 | Film-coated tablet | 63.80 | Details |
| LETERMOVIR | PREVYMIS | 240 | Film-coated tablet | 20693.5 | Details |
| BENZOYL PEROXIDE,ADAPALENE | Deriva BPO | 25,1 | Gel | 40.30 | Details |
| ROMOSOZUMAB | Evenity | 105 | Solution for injection in pre-filled syringe | 1809 | Details |
| ONDANSETRON | Kromafina solution 4 mg/5 ml | 0.8 | Oral solution | 97.95 | Details |
| TERIPARATIDE | TERROSA | 250 | Solution for injection | 1003.05 | Details |
| MONTELUKAST SODIUM | Broncast Pediatric Chewable Tablet | 4 | Chewable tablet | 60.00 | Details |
| BUROSUMAB | CRYSVITA | 10 | Solution for injection | 13256.95 | Details |
| BUROSUMAB | CRYSVITA | 20 | Solution for injection | 26513.90 | Details |
| BUROSUMAB | CRYSVITA | 30 | Solution for injection | 39770.75 | Details |
| LINACLOTIDE | LINZESS | 290 | Capsule | 204.10 | Details |
| MOXIFLOXACIN HYDROCHLORIDE | VIAGACIN | 400 | Film-coated tablet | 58.60 | Details |
| MOXIFLOXACIN HYDROCHLORIDE | VIAGACIN | 400 | Film-coated tablet | 41.85 | Details |
| AVELUMAB | BAVENCIO | 20 | Solution for infusion | 4438.00 | Details |
| PACLITAXEL | ABRAXANE | 5 | Powder for suspension | 1157.05 | Details |
| BISACODYL | DulcoLax 5MG ENTERIC COATED TABLET | 5 | Coated tablet | 14.55 | Details |
6.18% of users said yes from 275 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.